GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Lifepoint Hospitals, Inc. (LPNT) [hlAlert]

Rating:
Buy LPNT
up 125.44 %

Lifepoint Hospitals, Inc. (LPNT) upgraded to Buy with price target $41 by Auriga

Posted on: Wednesday,  May 23, 2012  1:25 PM ET by Auriga

Auriga rated Buy Lifepoint Hospitals, Inc. (NASDAQ: LPNT) on 05/23/2012, when the stock price was $35.65. Since
then, Lifepoint Hospitals, Inc. has gained 125.44% as of 01/11/2016's recent price of $80.37.
If you would have followed this Auriga's recommendation on LPNT, you would have gained 125.44% of your investment in 1328 days.

LifePoint Hospitals, Inc. is engaged in the operation of general, acute care hospitals in non-urban communities. The company's general, acute care hospitals usually provide the range of medical and surgical services commonly available in hospitals in non-urban markets. These hospitals also provide diagnostic and emergency services, as well as outpatient and ancillary services including outpatient surgery, laboratory, radiology, respiratory therapy and physical therapy.

Auriga operates full-service institutional equity and fixed income trading desks with state-of-the-art communications technology and trading systems. Through our U.S. corprate parent, Auriga Holdings, LLC we offer a variety of services including whole loan trading and asset management. Through our Spanish parent company, Auriga Securities Sociedad de Valores, S.A., we offer the ability to trade European equity and fixed income products. We connect electronically to buy-side firms; route orders to multiple points of execution and subsequently route to our clearing firm, Pershing, for settlement.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/23/2012 1:25 PM Buy
None
35.65 41.00
as of 12/31/2012
1 Week down  -0.99 %
1 Month up  4.91 %
3 Months down  -11.75 %
1 YTD up  5.89 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/22/2011 8:25 AM Hold
None
38.87 41.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy